4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide methanesulfonate, 99%
cas: 857890-39-2 — see every product listed under this CAS number, including other names
4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide methanesulfonate, 99% (CAS 857890-39-2) is a chemical reagent available from Chemat. Available pack sizes: 100mg, 250mg, 1g, 5g, 25g. Offered by: BLDpharm.
| brand | BLDpharm |
|---|---|
| catalog number | BD626836-100mg |
| cas | 857890-39-2 |
| size | 100mg |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| BLDpharm | 100mg | 125.54 Pln | |
| BLDpharm | 250mg | 164.41 Pln | |
| BLDpharm | 1g | 269.93 Pln | |
| BLDpharm | 5g | 642.02 Pln | |
| BLDpharm | 25g | 2124.83 Pln |
properties
| purity | 99% |
|---|---|
| delivery time | 1-2 weeks |
Lenvatinib mesylate is a methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine. It has a role as an antineoplastic agent, an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor, a fibroblast growth factor receptor antagonist, a vascular endothelial growth factor receptor antagonist and an orphan drug. It contains a lenvatinib(1+).
Source: ChEBI
| Molecular formula | C22H23ClN4O7S |
|---|---|
| Molecular weight | 523.0 g/mol |
| IUPAC name | 4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;methanesulfonic acid |
| InChIKey | HWLFIUUAYLEFCT-UHFFFAOYSA-N |
| SMILES | COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O |
Computed by PubChem (NCBI)